Transcriptional repressor B lymphocyte-induced maturation protein-1 (Blimp-1) is a master regulator of plasma cell differentiation. Here we show that Blimp-1 is covalently modified by SUMO1 at lysine 816, a modification mediated by SUMO E3 ligase PIAS1. Mutation of Blimp-1 lysine 816 reduces transcriptional repression-correlating with a reduced interaction with a histone deacetylase, HDAC2-and impairs differentiation of antibody-secreting cells. Thus, the SUMO pathway critically regulates Blimp-1 function during plasma cell differentiation.
INTRODUCTION
B lymphocyte-induced maturation protein-1 (Blimp-1), a transcriptional repressor, has a central role in the differentiation of B cells into antibody-secreting plasma cells [1] as well as many other cell lineages of multiple organisms [2] . Although plasma cell fate specification can be initiated independently of Blimp-1, Blimp-1 is required for complete plasma cell differentiation [3] . Blimp-1 is present in virtually all plasma cells induced by T celldependent or -independent antigen immunization [4] , and gene-targeted deletion of the Blimp-1 gene, Prdm1, in mouse B cells blocks their ability to mount an antibody response [1] .
By interacting with several chromatin-modifying enzymes including HDAC1/2 [5] , Blimp-1 suppresses genes implicated in proliferation and in the mature B-cell transcription programme [6] [7] [8] [9] , leading to the specification of plasma cell fate. Blimp-1 was recently shown to be modified by SUMO1 [10] , but the underlying molecular and biological consequences are not known.
SUMOylation, a post-translational modification that involves the covalent conjugation of the SUMO protein to a target substrate, regulates many important molecular and cellular processes, including transcriptional control [11] . The conjugation of SUMO with its substrate involves the E3 ligases, which enhance substrate selectivity in vivo [12] . The PIAS family, one of the three types of mammalian E3 ligases, consists of four proteins: PIAS1, PIAS2 (PIAS2-a and PIAS2-b), PIAS3 and PIAS4 [13] . The interactions of transcription factors with PIAS proteins can either positively or negatively affect transcriptional activities [14] .
In this report, we demonstrate the significance of PIAS1-dependent SUMOylation of Blimp-1 in plasma cell differentiation.
RESULTS

Blimp-1 is modified by SUMO1 at Lys816
We first verified by co-immunoprecipitation (co-IP) that endogenous Blimp-1 is sumoylated in plasma cells NCI-H929 (H929) that constitutively express Blimp-1, and in lipopolysaccharide (LPS)-stimulated mouse splenic B cells that express induced Blimp-1. Indeed, SUMO1 is present in anti-Blimp-1 immunoprecipitates in both cultured cells, and the slower-migrating form shows a molecular-weight shift of SUMO1 conjugate, which suggests the sumoylated Blimp-1 ( Fig 1A) . Protein SUMOylation occurs at the lysine (K) residue of the consensus SUMOylation motif, cKXE, where c represents hydrophobic residues and X represents any amino acid [15] . Using the computational SUMOylation prediction programme SUMOsp [16] , we found that there are five putative SUMOylation sites in human Blimp-1, which are located at amino-acid residues K235, K245, K574, K767 and K816 (accession number NP_001189 Fig 1B) and are conserved in mouse Blimp-1. Five individual Blimp-1 mutants, K235R, K245R, K574R, K767R and K816R, each of which contains a different mutated SUMO acceptor site, were generated. These FLAGtagged (FLAG-)Blimp-1 mutants were expressed in the nucleus (supplementary Fig S1A online) . Immunoblot (IB) analysis using cell lysates from 293T cells transfected with vectors expressing FLAG-Blimp-1 or various FLAG-Blimp-1 mutants and enhanced green fluorescent protein (EGFP)-SUMO1 demonstrated that, similar to wild-type (WT) Blimp-1, K235R, K245R, K574R and K767R Blimp-1 were sufficient to conjugate with EGFP-SUMO1, because a protein species with a higher molecular mass (B150 kDa) corresponding to the addition of EGFP-SUMO1 conjugate was detected (Fig 1C) . In sharp contrast, K816R Blimp-1 failed to be sumoylated (Fig 1C) . Another Blimp-1 mutant, E818A, which carries the disrupted VKQE SUMOylation motif in Blimp-1, was also not modified by SUMO1 (Fig 1D) . An in vitro SUMOylation assay further demonstrated that WT, K235R, K245R, K574R and K767R Blimp-1 were conjugated to SUMO in vitro, whereas K816R Blimp-1 failed to be sumoylated (Fig 1E) , showing again that K816 is the major SUMO acceptor site of Blimp-1. Indeed, liquid chromatography-tandem mass spectrometry revealed a SUMO peptide branch at K816 of Blimp-1. Lysates prepared from 293T cells that transiently expressed FLAG-Blimp-1 and EGFP-SUMO1 and that had been processed for anti-FLAG IP and trypsin digestion were used for liquid chromatography-tandem mass spectrometry identification (Fig 1F) . Along this line, we wondered whether SUMO2 or SUMO3 can, like SUMO1, modify Blimp-1. In spite of the similar expression levels of all three EGFP-SUMOs, EGFP-SUMO2 and EGFP-SUMO3 failed to conjugate with Blimp-1 (supplementary Fig S2 online) .
SUMOylation of Blimp-1 is of functional importance
Prdm1-deficient (knockout (KO)) splenic B cells that are stimulated in vitro by LPS fail to cease cell cycling and to commit to the plasma cell fate [1] . To address the biological importance of SUMO modification of Blimp-1, we examined the proliferation rate of LPS-stimulated KO B cells that were retrovirally reconstituted with WT or K816R Blimp-1. Proliferation rate was monitored by dilution of the fluorescent tracking dye PKH26. Notably, after stimulation, cell proliferation was halted by WT Blimp-1, but K816R-expressing cells divided as effectively as cells that had been transduced with control vector (Fig 2A) . Consistently, transduction of WT or K245R Blimp-1 in stimulated KO B cells restored the formation of plasmacytic cells that express the CD138 plasma cell surface marker (Fig 2B) . In contrast, despite the similar expression of the reconstituted Blimp-1 proteins (supplementary Fig S3 online) , the frequency of CD138 þ cells generated by K816R reconstitution was reduced (Fig 2B) . Similarly, K816R, unlike WT and K245R Blimp-1, was much less able to compensate for IgM production in KO B cells (Fig 2C) . The suggestion that disruption of SUMOylation of Blimp-1 impairs its ability to trigger the plasma cell fate was further supported by another reconstitution assay in which E818A Blimp-1 was expressed in LPS-stimulated KO B cells and led to results that were similar to K816R expression (Fig 2B,C) .
Re-introduction of WT Blimp-1 in KO B cells resulted in downregulation of Pax5 and upregulation of Xbp1 (Fig 2D) , a crucial gene for antibody secretion [17] . The induction of Xbp1 is due to the de-repression effect from Blimp-1-mediated suppression of the gene encoding Pax5, which suppresses Xbp1 [8] . The mRNA1 level for Pax5 was repressed less, and the induction of Xbp1 mRNA was hampered in cells that expressed K816R Blimp-1 ( Fig 2D) . Similarly, the other two Blimp-1 target genes, Ciita and Bcl2a1 [7, 18] , were repressed less by K816R than by WT Blimp-1 (Fig 2D) , in agreement with the less-differentiated phenotype in K816R-expressing cells.
Together, these data show that Blimp-1, in the absence of SUMOylation, is not as effective at blocking cell proliferation and is defective in driving plasma cell formation.
Involvement of PIAS1 in Blimp-1 SUMOylation
We next dissected the SUMO pathways that contribute to Blimp-1 SUMOylation. Various haemagglutinin-tagged human E3 ligases, including PIAS1, PIAS2-a, PIAS2-b, PIAS3 and PIAS4, were used to test their effects on Blimp-1 SUMOylation. Interestingly, PIAS1 dramatically enhanced Blimp-1 SUMOylation, even though the expression of PIAS1 was lower than that of the other PIAS proteins (Fig 3A) . In contrast, PIAS3 was much less capable of promoting Blimp-1 SUMOylation, and PIAS2-a, PIAS2-b and PIAS4 were nearly inert in the co-transfection assay (Fig 3A) . The direct effect of PIAS1 on promoting Blimp-1 SUMOylation was confirmed by an in vitro SUMOylation assay in which bacterially expressed PIAS1 was able to further increase the SUMO1-modified Blimp-1 in a dose-dependent manner (Fig 3B) . We also detected the interaction between Blimp-1 and PIAS1 at endogenous levels by co-IP in lysates from H929 plasma cells (Fig 3C) . The RING-fingerlike zinc-binding domain (RLD) of PIAS1 has the SUMO E3 ligase enzymatic activity [13] . We found that PIAS1 without the RLD (DRLD) had decreased ability to promote SUMO1 conjugation with Blimp-1 (Fig 3D) , indicating that the RLD domain of PIAS1 is required in this context. Similarly, depletion of PIAS1 by a lentiviral vector that expresses the short hairpin RNA against PIAS1, PIAS1i, led to reduced SUMO1 conjugation as compared with the effect of the control short hairpin RNA, Ctrli (Fig 3E) .
We mapped the Blimp-1 region involved in the PIAS1 interaction by using various plasmids encoding deleted forms of FLAG-Blimp-1 (supplementary Fig S4A online) . These deleted forms of FLAG-Blimp-1 were expressed in the nucleus (supplementary Fig S1B online) . Analysis indicated that aminoacid residues 527-574 of Blimp-1 were crucial for the PIAS1 interaction (supplementary Fig S4B online) . As expected, a Blimp-1 deletion lacking this region (D527-574) failed to interact with PIAS1 ( Fig 3F) and was less able to be modified by EGFP-SUMO1 (Fig 3G) . LPS-stimulated KO B cells expressing the D527-574 Blimp-1 mutant showed decreased formation of CD138 þ plasmacytic cells (Fig 3H) and IgM production (Fig 3I) as compared with cells that expressed WT Blimp-1, even though both proteins were expressed at similar levels (supplementary Fig S3 online) .
As the interaction with PIAS1 appears to be important for the effect of Blimp-1, we wondered whether PIAS1 contributes to plasma cell differentiation. Indeed, knockdown of PIAS1 in LPStriggered differentiating splenic B cells caused reduced production of antibody (Fig 3J) . However, it remains possible that knocking down PIAS1 during plasma cell differentiation may also affect the Blimp-1. We thus ectopically expressed Blimp-1 in a human lymphoblastoid cell line SKW 6.4 (SKW) possessing the ability to produce IgM [9] , and found that knockdown of PIAS1 reduced Blimp-1-driven IgM production (Fig 3K) . This result is consistent with another observation that SKW cells that were transduced with K816R Blimp-1 produced less IgM when compared with WT Blimp-1-transduced SKW cells (supplementary Fig S5 online) .
SUMO affects transcriptional repression by Blimp-1
Lastly, we examined the molecular mode of action underlying the consequence of Blimp-1 SUMOylation. Cycloheximide-based protein chase experiment showed that K816R Blimp-1 is not markedly different with respect to its protein stability, in comparison with WT Blimp-1 (Fig 4A) . We next examined if SUMO-modified Blimp-1 has changed transcriptional repression activity. We previously showed that Blimp-1 fused with the Gal-4 DNA-binding domain (DBD-Blimp-1) effectively suppresses SUMO 4 -tk-Luc [19] . Here the (Gal4) 4 -tk-driven luciferase activity was suppressed by DBD-Blimp-1, but was suppressed to a lesser extent by DBD-K816R Blimp-1 (Fig 4B) . Similar results were observed in Blimp-1-dependent repression of the activities of the CIITA promoter III (Fig 4C) . These data suggest that a SUMO conjugation-defective Blimp-1 is a less potent transcriptional repressor.
We next determined whether the effect of SUMOylation on the transcriptional repression ability of Blimp-1 results from an alteration in the DNA-binding ability of Blimp-1. WT Blimp-1 and K816R bound similarly with the endogenous target gene loci, as demonstrated by the anti-Blimp-1 chromatin IP assay, which examined the binding of WT Blimp-1 and K816R with endogenous target sites, including Myc, Pax5 and Ciita, in B cells (Fig 4D) . HDAC1/2 is involved in Blimp-1-mediated gene suppression [5] . We found that HDAC2 was co-immunoprecipitated with WT Blimp-1, as expected (Fig 4E) . Notably, the level of HDAC2 that interacted with K816R Blimp-1 was statistically decreased (Fig 4E) .
DISCUSSION
Here we provide evidence that, among SUMO family members, SUMO1 selectively mediated Blimp-1 SUMOylation and that Blimp-1 is subjected to PIAS1-mediated SUMOylation at lysine 816, which has a crucial role in plasma cell differentiation. We here show that the expression of Blimp-1 downstream genes, including Pax5, Ciita, Bcl2a1 and Xbp1, was altered in K816R-reconstituted KO B cells when compared with that in WT Blimp-1-reconstituted cells. The changes in the expression of these genes in K816R-versus WT Blimp-1-rescued cells are marginal but statistically significant, which could be due to the heterogeneity of splenic B cells that leads to unsynchronized differentiation. Additionally, the reason that SUMOylation-defective forms of Blimp-1 cannot drive plasma cell fate is not due to their influence on cell viability, because we observed a similar apoptotic rate in cells reconstituted with mutated or WT Blimp-1 (supplementary Fig S6 online) .
Although there are five members of the PIAS family and all are expressed in mouse splenic B cells (unpublished observations), PIAS1 functioned most effectively as the E3 SUMO ligase of Blimp-1. The interaction between Blimp-1 and PIAS1 appears to be of biological importance, as a Blimp-1 mutant that lacks the region required for PIAS1 interaction was much less capable of promoting plasma cell differentiation. Also, depletion of PIAS1 attenuated the Blimp-1-mediated production of IgM. In addition to serving as a SUMO E3 ligase, PIAS1 is a transcriptional co-repressor for some transcription factors, whereby it prevents their binding to target genes without the involvement of SUMO [20] . Our result that lack of RLD in PIAS1 shows reduced ability to promote Blimp-1 SUMOylation suggests that PIAS1 relies on its E3 ligase domain to regulate Blimp-1. In many cases, SUMO modification converts the function of transcription factors from positive to negative regulators [21] . It appears that SUMO-modified Blimp-1 is a more potent transcriptional repressor. In the case of K816R Blimp-1, its reduced transcriptional repression may not result from globally changing subcellular localization, as immunofluorescence staining illustrated that the majority of WT and K816R Blimp-1 had a speckled nuclear distribution pattern and that WT and K816R Blimp-1 did not co-localize with promyelocytic leukaemia protein (supplementary Fig S7 online) . It is more likely that the level of HDAC2 that interacted with K816R Blimp-1 was decreased. Although a recent paper suggested that SUMOylation results in proteasomal degradation of Blimp-1 [10] , we did not observe that an absence of the SUMOylation site affected Blimp-1 expression. It is possible that the fusion of SUMO1 to the amino terminus of Blimp-1, the approach used in that study, caused the conflicting observation.
In summary, our study here provides a mechanistic insight into the modulation of cell proliferation and plasma cell fate commitment through a SUMO site in the master regulator Blimp-1, which may provide new strategies for regulating humoral immune responses.
METHODS
Detailed experimental procedures are described in the supplementary information online. IP and IB analyses. IP and IB analyses were performed as described [19] . Antibodies used in this study are described in the supplementary information online. Transfection and luciferase reporter assay. The luciferase reporter fused to the CIITA promoter III was described previously [7] . Renilla luciferase reporter driven by the tk promoter (RL-tk) was used for normalization. Mouse 18-81 pre-B cells were transfected by electroporation; the amounts of DNA were chosen and the procedure performed as described previously [5] . Cells were lysed 24 h after transfection and were used for measurement of firefly luciferase and Renilla luciferase activities using the DualLuciferase Reporter s Assay kit (Promega). The luminescence was detected by TopCount NXTt (Perkin Elmer). Fold repression was calculated as described [19] . Generation of retrovirus or lentivirus and virus transduction. The procedure for preparing viral vectors was as described [19] . B cells were transduced with virus, at a multiplicity of infection of 5-10 for lentiviral transduction or 1-5 for retroviral transduction, in the presence of 5 mg/ml of polybrene. Transduced B cells were analysed or sorted by flow cytometry 2-3 days after infection. Statistics. Statistical significance was determined by two-tailed Student's t-tests. Po0.05 was considered significant. Data shown here are the mean ± s.d. from at least three experiments unless otherwise indicated. Supplementary information is available at EMBO reports online (http://www.emboreports.org).
